SCHEMBL18156898

SCHEMBL18156898

CC(C)(OCc1ccccc1)c1ccc(N)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOB P27338 8/20 0.50
RAB9A P51151 4/20 0.50
MAOA P21397 3/20 0.50
MAPT P10636 3/20 0.50
GAA P10253 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SLC6A2 P23975 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
MAPK1 P28482 2/20 0.41
IDO1 P14902 1/20 0.41
PTPN1 P18031 1/20 0.40
NPC1 O15118 3/20 0.40
AGXT P21549 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9176021 0.87 MAPK1 (0.54) MAPTL3MBTL1SLC6A2TAAR1MAPK1
SCHEMBL9956202 0.78 MAPK1 (0.43) MAOBMAPTL3MBTL1TAAR1MAPK1
SCHEMBL16799942 0.76 RORC (0.51) MAOBRAB9AMAOAMAPTGAA
SCHEMBL18156896 0.76 MAPT (0.46) MAOBRAB9AMAPTGAAL3MBTL1
SCHEMBL28778426 0.75 MAPK1 (0.45) MAOBRAB9AMAOASMN1; SMN2L3MBTL1
SCHEMBL27753299 0.75 MAPK1 (0.45) SLC6A2TAAR1MAPK1PTPN1ALDH1A1
SCHEMBL18156893 0.75 MAPT (0.48) MAOBRAB9AMAOAMAPTGAA
SCHEMBL10656078 0.75 MAOB (0.40) MAOBRAB9AMAOAMAPTGAA
SCHEMBL10838625 0.73 TAAR1 (0.54) MAOBRAB9AMAOAMAPTGAA
SCHEMBL11957416 0.72 ALDH1A1 (0.44) MAOBRAB9AMAOAMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738600-B2 ROR gamma (RORγ) modulators LEAD PHARMA CEL MODELS IP B.V. (NL) 2017-08-22 US disclosed
US-20160304448-A1 ROR GAMMA (RORy) MODULATORS LEAD PHARMA CEL MODELS IP B.V. (NL) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160304448-A1 ROR GAMMA (RORy) MODULATORS RORC, RORA, RORB MAOB 3661/4885RAB9A 1093/4885MAOA 3846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.